| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
3e-10 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
4e-09 |
| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
3e-08 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
5e-08 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
1e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
3e-07 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
7e-07 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
7e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
3e-06 |